The EU has approved the use of the Moderna vaccine for adolescents from 12 years old

The EU’s drug regulator – the European Medicines Agency (EMA), has approved the use of the Moderna coronavirus vaccine for vaccination of adolescents aged 12-17 years, the agency said in a statement.

“After evaluating the received data, the EMA can recommend the use of the Moderna vaccine for adolescents aged 12 to 17 years… The use of the vaccine in children from the age of 12 will be the same as in other age categories: the vaccine is administered in two doses to the shoulder muscle at intervals of four weeks,” the document says.

Until recently, Moderna was approved for use in the EU from the age of 18. Currently, the Pfizer/BioNTech vaccine is already used in the European Union to vaccinate adolescents from the age of 12.

In total, four vaccines are approved for use in adults in the EU: Pfizer/Biotech, Moderna, AstraZeneca, and Johnson&Johnson. Several other drugs are under consideration by the regulator, including the Russian Sputnik V vaccine.

The European Union intends to fully vaccinate 70% of the adult population against coronavirus by the end of July. At the moment, almost 55% of adult residents of the union have already been fully vaccinated.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: